Rockwell Medical, Inc.
RMTI· Nasdaq
RMTIRockwell Medical, Inc.
Filed Mar 31, 2021 · 10-K · 90 days after period end · 0001628280-21-006280
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017 |
|---|---|---|---|---|
| Revenue | $15.16M | $15.49M | $16.85M | $14.84M |
| Net Income | -$8.66M | -$7.30M | -$9.38M | -$9.04M |
| EPS Diluted | — | — |
Rockwell Medical, Inc. · CIK 1041024 · Engraved from SEC EDGAR
| — |
| -$0.18 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2020 · filed Mar 31, 2021 · 90 d after period end
